Actemra 160mg, a drug known scientifically as tocilizumab, functions as a potent therapeutical agent primarily employed for the control of rheumatoid arthritis. This effective substance functions by inhibiting the activity of interleukin-6 (IL-6), a regulatory protein crucial in the inflammatory process. Moreover, Actemra has shown efficacy in the